McKinzie DL - Search Results

1

Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia.

Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dubé S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC. Shekhar A, et al. Among authors: mckinzie dl. Am J Psychiatry. 2008 Aug;165(8):1033-9. doi: 10.1176/appi.ajp.2008.06091591. Epub 2008 Jul 1. Am J Psychiatry. 2008. PMID: 18593778 Clinical Trial.

2

Muscarinic mechanisms in psychotic disorders.

McKinzie DL, Bymaster FP. McKinzie DL, et al. Handb Exp Pharmacol. 2012;(213):233-65. doi: 10.1007/978-3-642-25758-2_9. Handb Exp Pharmacol. 2012. PMID: 23027418 Review.

3

Muscarinic receptors as a target for drugs treating schizophrenia.

Bymaster FP, Felder C, Ahmed S, McKinzie D. Bymaster FP, et al. Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):163-81. doi: 10.2174/1568007024606249. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769625 Review.

4

The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain.

Montani C, Canella C, Schwarz AJ, Li J, Gilmour G, Galbusera A, Wafford K, Gutierrez-Barragan D, McCarthy A, Shaw D, Knitowski K, McKinzie D, Gozzi A, Felder C. Montani C, et al. Neuropsychopharmacology. 2021 May;46(6):1194-1206. doi: 10.1038/s41386-020-00916-0. Epub 2020 Dec 20. Neuropsychopharmacology. 2021. PMID: 33342996 Free PMC article.

5

Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.

Bymaster FP, McKinzie DL, Felder CC, Wess J. Bymaster FP, et al. Among authors: mckinzie dl. Neurochem Res. 2003 Apr;28(3-4):437-42. doi: 10.1023/a:1022844517200. Neurochem Res. 2003. PMID: 12675128 Review.

6

Muscarinic mechanisms of antipsychotic atypicality.

Bymaster FP, Felder CC, Tzavara E, Nomikos GG, Calligaro DO, Mckinzie DL. Bymaster FP, et al. Among authors: mckinzie dl. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1125-43. doi: 10.1016/j.pnpbp.2003.09.008. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 14642972 Review.

7

Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.

Tzavara ET, Bymaster FP, Felder CC, Wade M, Gomeza J, Wess J, McKinzie DL, Nomikos GG. Tzavara ET, et al. Among authors: mckinzie dl. Mol Psychiatry. 2003 Jul;8(7):673-9. doi: 10.1038/sj.mp.4001270. Mol Psychiatry. 2003. PMID: 12874603

8

Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.

Watt ML, Schober DA, Hitchcock S, Liu B, Chesterfield AK, McKinzie D, Felder CC. Watt ML, et al. J Pharmacol Exp Ther. 2011 Aug;338(2):622-32. doi: 10.1124/jpet.111.182063. Epub 2011 May 10. J Pharmacol Exp Ther. 2011. PMID: 21558436

9

M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.

Tzavara ET, Bymaster FP, Davis RJ, Wade MR, Perry KW, Wess J, McKinzie DL, Felder C, Nomikos GG. Tzavara ET, et al. Among authors: mckinzie dl. FASEB J. 2004 Sep;18(12):1410-2. doi: 10.1096/fj.04-1575fje. Epub 2004 Jul 1. FASEB J. 2004. PMID: 15231726

10

Elucidating the role of muscarinic receptors in psychosis.

Felder CC, Porter AC, Skillman TL, Zhang L, Bymaster FP, Nathanson NM, Hamilton SE, Gomeza J, Wess J, McKinzie DL. Felder CC, et al. Among authors: mckinzie dl. Life Sci. 2001 Apr 27;68(22-23):2605-13. doi: 10.1016/s0024-3205(01)01059-1. Life Sci. 2001. PMID: 11392633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters